Guangdong Transtek Medical Electronics (SZSE:300562) - Share price, News & Analysis

Q: What is the Fair Price of 300562 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

300562 (CN¥9.85) is trading above our estimate of [[fair value]] (CN¥0.22)

300562 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	5/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

300562 Stock Overview

Guangdong Transtek Medical Electronics Co., Ltd designs, manufactures, and sells medically approved products, connected healthcare devices, and smart wearables in China.

Rewards

Earnings are forecast to grow 57.71% per year

Risk Analysis

No risks detected for 300562 from our risk checks.

Guangdong Transtek Medical Electronics Competitors

Jiangsu Apon Medical Technology

SZSE:300753

CN¥1.8b

Maider Medical Industry Equipment

SHSE:688310

CN¥1.9b

Guangdong Biolight Meditech

SZSE:300246

CN¥2.8b

Zhejiang Canaan Technology

SZSE:300412

CN¥3.7b

Price History & Performance

Summary of all time highs, changes and price drops for Guangdong Transtek Medical Electronics
Historical stock prices
Current Share Price	CN¥9.85
52 Week High	CN¥18.80
52 Week Low	CN¥8.10
Beta	0.71
1 Month Change	1.76%
3 Month Change	6.49%
1 Year Change	-27.09%
3 Year Change	-22.81%
5 Year Change	-52.83%
Change since IPO	40.03%

Shareholder Returns

	300562	CN Medical Equipment	CN Market
7D	3.0%	0.4%	1.3%
1Y	-27.1%	-23.7%	-7.2%

Return vs Industry: 300562 underperformed the CN Medical Equipment industry which returned -23.7% over the past year.

Return vs Market: 300562 underperformed the CN Market which returned -7.2% over the past year.

Price Volatility

Is 300562's price volatile compared to industry and market?
300562 volatility
300562 Average Weekly Movement	4.8%
Medical Equipment Industry Average Movement	5.6%
Market Average Movement	6.0%
10% most volatile stocks in CN Market	9.2%
10% least volatile stocks in CN Market	3.8%

Stable Share Price: 300562 is less volatile than 75% of CN stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 300562's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2002	2,190	n/a	https://www.transtek.cn

Guangdong Transtek Medical Electronics Co., Ltd designs, manufactures, and sells medically approved products, connected healthcare devices, and smart wearables in China. The company offers remote patient monitoring devices, blood pressure monitors, electronic scales, multifunctional wearable, and wireless hearable devices. Guangdong Transtek Medical Electronics Co., Ltd was founded in 2002 and is based in Zhongshan, China.

Guangdong Transtek Medical Electronics Fundamentals Summary

How do Guangdong Transtek Medical Electronics's earnings and revenue compare to its market cap?
300562 fundamental statistics
Market Cap	CN¥2.11b
Earnings (TTM)	-CN¥2.82m
Revenue (TTM)	CN¥1.72b

1.2x

P/S Ratio

-749.0x

P/E Ratio

Is 300562 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
300562 income statement (TTM)
Revenue	CN¥1.72b
Cost of Revenue	CN¥1.39b
Gross Profit	CN¥329.16m
Other Expenses	CN¥331.98m
Earnings	-CN¥2.82m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.013
Gross Margin	19.18%
Net Profit Margin	-0.16%
Debt/Equity Ratio	1.5%

How did 300562 perform over the long term?

See historical performance and comparison

Dividends

0.1%

Current Dividend Yield

-74%

Payout Ratio

We’ve recently updated our valuation analysis.

Valuation

Is 300562 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300562?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 300562. This is calculated by dividing 300562's market cap by their current preferred multiple.
What is 300562's n/a Ratio?
n/a Ratio	0x
n/a	n/a
Market Cap	CN¥2.11b

300562 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.9x
Enterprise Value/EBITDA	178.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 300562's PS Ratio compare to its peers?

300562 PS Ratio vs Peers

The above table shows the PS ratio for 300562 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	PS	Estimated Growth	Market Cap
Peer Average	4x
300753 Jiangsu Apon Medical Technology	4.1x	n/a	CN¥1.8b
688310 Maider Medical Industry Equipment	6x	n/a	CN¥1.9b
300246 Guangdong Biolight Meditech	2.5x	n/a	CN¥2.8b
300412 Zhejiang Canaan Technology	3.3x	n/a	CN¥3.7b
300562 Guangdong Transtek Medical Electronics	1.2x	30.9%	CN¥2.1b

Price-To-Sales vs Peers: 300562 is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (4x).

Price to Earnings Ratio vs Industry

How does 300562's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

Price-To-Sales vs Industry: 300562 is good value based on its Price-To-Sales Ratio (1.2x) compared to the CN Medical Equipment industry average (6.2x)

Price to Sales Ratio vs Fair Ratio

What is 300562's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300562 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1.2x
Fair PS Ratio	2.2x

Price-To-Sales vs Fair Ratio: 300562 is good value based on its Price-To-Sales Ratio (1.2x) compared to the estimated Fair Price-To-Sales Ratio (2.2x).

Share Price vs Fair Value

What is the Fair Price of 300562 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300562 (CN¥9.85) is trading above our estimate of fair value (CN¥0.22)

Significantly Below Fair Value: 300562 is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Guangdong Transtek Medical Electronics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

5/6

Future Growth Score 5/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

57.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300562 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.2%).

Earnings vs Market: 300562 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 300562 is expected to become profitable in the next 3 years.

Revenue vs Market: 300562's revenue (30.9% per year) is forecast to grow faster than the CN market (17.8% per year).

High Growth Revenue: 300562's revenue (30.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300562's Return on Equity is forecast to be low in 3 years time (13.4%).

Discover growth companies

Past Performance

How has Guangdong Transtek Medical Electronics performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

5.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 300562 is currently unprofitable.

Growing Profit Margin: 300562 is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: 300562 is unprofitable, but has reduced losses over the past 5 years at a rate of 5% per year.

Accelerating Growth: Unable to compare 300562's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300562 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (9.2%).

Return on Equity

High ROE: 300562 has a negative Return on Equity (-0.84%), as it is currently unprofitable.

Discover strong past performing companies

Financial Health

How is Guangdong Transtek Medical Electronics's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: 300562's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥547.8M).

Long Term Liabilities: 300562's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥34.0M).

Debt to Equity History and Analysis

Debt Level: 300562 has more cash than its total debt.

Reducing Debt: 300562's debt to equity ratio has increased from 1.1% to 1.5% over the past 5 years.

Debt Coverage: 300562's debt is well covered by operating cash flow (308.2%).

Interest Coverage: Insufficient data to determine if 300562's interest payments on its debt are well covered by EBIT.

Balance Sheet

Discover healthy companies

Dividend

What is Guangdong Transtek Medical Electronics's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage

0.10%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 300562's dividend (0.1%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.44%).

High Dividend: 300562's dividend (0.1%) is low compared to the top 25% of dividend payers in the CN market (1.87%).

Stability and Growth of Payments

Stable Dividend: 300562 is not paying a notable dividend for the CN market, therefore no need to check if payments are stable.

Growing Dividend: 300562 is not paying a notable dividend for the CN market, therefore no need to check if payments are increasing.

Earnings Payout to Shareholders

Earnings Coverage: 300562 is not paying a notable dividend for the CN market.

Cash Payout to Shareholders

Cash Flow Coverage: 300562 is not paying a notable dividend for the CN market.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.3yrs

Average board tenure

CEO

Guangdong Transtek Medical Electronics has no CEO, or we have no data on them.

Board Members

Experienced Board: 300562's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/08/17 00:00
End of Day Share Price	2022/08/17 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31